eNauka - pregled
Pregled prema Projekat JanssenJohnson & Johnson USAJanssen Biotech Inc
Prikaz rezultata 1 do 4 od 4
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2016 | Impact of Treatment with Iron Chelators in Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry | Langemeijer, Saskia; ...; Savic, Aleksandar D | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2016 | Longer Term Efficacy and Safety of Subcutaneous Compared with Intravenous Rituximab: Updated Results of the Phase 3 SABRINA Study | Davies, Andrew J; Mihaljevic, Biljana S
Macdonald, David;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2020 | Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study | Moens, Annick; ...; Milenkovic, Zoran; ...; (broj, koautora 25) | Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
| 2018 | Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness![]() | Spyropoulos, Alex C
Stanković, Dušica; Stanković, Aleksandra D.
| Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
